Publications by authors named "Sandra Althouse"

Claim this Profile
C
Characteristics and Outcomes of Acute Leukemias in Adolescents and Young Adults with Down Syndrome: A Single-Center Experience.
Marie Nour Karam, Sandra K Althouse, Madeline G Andrews, Jenny Chen, Sandeep Batra

Hematol Rep· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Personalized Risk Messages on Uptake of Colorectal Cancer Screening : A Randomized Controlled Trial.
Peter H Schwartz, Susan M Perkins, Susan M Rawl, Karen K Schmidt, Sandra Althouse

Ann Intern Med· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized phase II study of consolidation immunotherapy with nivolumab and ipilimumab or nivolumab alone following concurrent chemoradiotherapy for unresectable stage IIIA/IIIB non-small-cell lung cancer (NSCLC): Big Ten Cancer Research Consortium LUN16-081.
Greg Durm, Hirva Mamdani, Sandra Althouse, Susan Perkins, Salma K Jabbour

J Immunother Cancer· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of Immune-Related Adverse Events With Efficacy in Consolidation Nivolumab Plus Ipilimumab or Nivolumab Alone After Chemoradiation in Patients With Unresectable Stage III Nonsmall Cell Lung Cancer: An Exploratory Analysis From the Big 10 Cancer Research Consortium Study BTCRC LUN 16-081.
Cynthia X Wei, Sandra K Althouse, Hirva Mamdani, Nasser H Hanna, Greg A Durm

Clin Lung Cancer· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of Radiation Pneumonitis in a Phase 2 Study of Consolidation Immunotherapy With Nivolumab and Ipilimumab or Nivolumab Alone Following Concurrent Chemoradiation Therapy for Unresectable Stage IIIA/IIIB Non-Small Cell Lung Cancer.
Michael Weisman, Greg Durm, Misty Dawn Shields, Nasser H Hanna, Sandra Althouse

Int J Radiat Oncol Biol Phys· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Second Look: Retrospective Identification of Thrombotic Microangiopathy in Pediatric Stem Cell Transplant Patients With Veno-Occlusive Disease.
Mahvish Q Rahim, Cydney Nichols, Sandra Althouse, April L Rahrig

Pediatr Transplant· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prediction Model for Brain Metastasis in Patients With Metastatic Germ-Cell Tumors.
Tareq Salous, Ryan Ashkar, Sandra K Althouse, Clint Cary, Timothy Masterson

Cancer Med· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-dose chemotherapy and peripheral blood stem cell transplantation as salvage therapy in primary mediastinal nonseminomatous germ cell tumors: The Indiana University experience.
Noah H Richardson, Fadi Taza, Rafat Abonour, Sandra K Althouse, Ryan Ashkar

Cancer· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cognitive function in long-term testicular cancer survivors: impact of modifiable factors.
Paul C Dinh, Patrick O Monahan, Chunkit Fung, Howard D Sesso, Darren R Feldman, Sandra Althouse

JNCI Cancer Spectr· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comprehensive Audiologic Analyses After Cisplatin-Based Chemotherapy.
Victoria A Sanchez, Paul C Dinh, Patrick O Monahan, Sandra Althouse, Jennessa Rooker

JAMA Oncol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes in Patients With Postchemotherapy Residual Nonretroperitoneal Disease in Nonseminomatous Germ Cell Tumors.
Jennifer King, Ryan Ashkar, Kenneth Kesler, Sandra K Althouse, Nasser H Hanna

JAMA Oncol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular and clinical effects of aromatase inhibitor therapy on skeletal muscle function in early-stage breast cancer.
Tara A Seibert, Lei Shi, Sandra Althouse, Richard Hoffman, Bryan P Schneider

Sci Rep· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stromal heterogeneity may explain increased incidence of metaplastic breast cancer in women of African descent.
Brijesh Kumar, Aditi S Khatpe, Jiang Guanglong, Katie Batic, Poornima Bhat-Nakshatri, Sandra K Althouse

Nat Commun· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of Residual Nonretroperitoneal Disease in Postchemotherapy Nonseminomatous Germ-Cell Tumors.
Jennifer M King, Michael Cheng, Kenneth Kesler, Ryan Ashkar, Sandra K Althouse

J Clin Oncol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Late Relapse of Germ Cell Tumors After Prior Chemotherapy or Surgery-only.
Noah H Richardson, Sandra K Althouse, Ryan Ashkar, Clint Cary, Timothy Masterson

Clin Genitourin Cancer· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ADAM8 is expressed widely in breast cancer and predicts poor outcome in hormone receptor positive, HER-2 negative patients.
Stefania Pianetti, Kathy D Miller, Hannah H Chen, Sandra Althouse, Sha Cao

Cancer Cell Int· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Racial disparities in cascade testing for cancer predisposition genes.
Nawal M Kassem, Sandra K Althouse, Patrick O Monahan, Lisa Hayes, Sarah M Nielsen

Prev Med· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Brief Report of a Phase II trial Evaluating Efficacy and Safety of Hypomethylating Agent Guadecitabine in Combination With Carboplatin in Extensive Stage Small Cell Lung Cancer.
Cynthia X Wei, Hirva Mamdani, Ryan Gentzler, Maitri Kalra, Susan Perkins, Sandra Althouse

Clin Lung Cancer· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Maintenance Oral Etoposide After High-Dose Chemotherapy (HDCT) for Patients With Relapsed Metastatic Germ-Cell Tumors (mGCT).
Fadi Taza, Rafat Abonour, Mohammad Abu Zaid, Sandra K Althouse, Bilal Anouti

Clin Genitourin Cancer· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TONSL Is an Immortalizing Oncogene and a Therapeutic Target in Breast Cancer.
Aditi S Khatpe, Rebecca Dirks, Poornima Bhat-Nakshatri, Henry Mang, Katie Batic, Sandra Althouse

Cancer Res· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence and risk factors for ototoxicity after cisplatin-based chemotherapy.
Victoria A Sanchez, Paul C Dinh, Jennessa Rooker, Patrick O Monahan, Sandra K Althouse

J Cancer Surviv· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinicogenomic Landscape of Metastatic Thymic Epithelial Tumors.
Fatemeh Ardeshir-Larijani, Bryan P Schneider, Sandra K Althouse, Milan Radovich, Ashiq Masood

JCO Precis Oncol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 2 trial of chemotherapy plus pembrolizumab in patients with advanced non-small cell lung cancer previously treated with a PD-1 or PD-L1 inhibitor: Big Ten Cancer Research Consortium BTCRC-LUN15-029.
Tareq Salous, Nikhil A Shukla, Sandra K Althouse, Susan M Perkins, Muhammad Furqan

Cancer· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Measuring the Impact of Quantitative Information on Patient Understanding: Approaches for Assessing the Adequacy of Patient Knowledge about Colorectal Cancer Screening.
Joshua B Rager, Sandra Althouse, Susan M Perkins, Karen K Schmidt, Peter H Schwartz

MDM Policy Pract· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II study of buparlisib in relapsed or refractory thymomas.
Mohammad I Abu Zaid, Milan Radovich, Sandra Althouse, Hao Liu, Aaron J Spittler

Front Oncol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis